Id: | acc3845 |
Group: | 1sens |
Protein: | JNK |
Gene Symbol: | Mapk8 |
Protein Id: | P49185 |
Protein Name: | MK08_RAT |
PTM: | phosphorylation |
Site: | Thr183 |
Site Sequence: | RTAGTSFMMTPYVVTRYYRAP |
Disease Category: | Urinary and reproductive system diseases |
Disease: | Acute Kidney Injury |
Disease Subtype: | |
Disease Cellline: | |
Disease Info: | |
Drug: | Glutamine? |
Drug Info: | Glutamine is a non-essential amino acid that plays a crucial role in various physiological processes such as immune function and gut health. |
Effect: | modulate |
Effect Info: | "Glutamine plays a renal protective role by inducing the binding of Hsp70 to JNK, inhibiting JNK activation, thereby reducing 14 - 3 - 3 phosphorylation, suppressing Bax translocation and apoptosis." |
Note: | |
Score: | 4.0 |
Pubmed(PMID): | 19384198 |
Sentence Index: | 19384198_0 |
Sentence: | Glutamine attenuates tubular cell apoptosis in acute kidney injury via inhibition of the c-Jun N-terminal kinase phosphorylation of 14-3-3. |
Sequence & Structure:
MSRSKRDNNFYSVEIADSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCLKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMDLEERTKNGVIRGQPSPLGAAVINGSQHPVSSPSVNDMSSMSTDPTLASD
No data.
No data.
Protein Tractability:
source: Open TargetsNo data.
PTM Intensity:
source: CPTACNo data.
PTM-Disease Association:
source: PTMDResidue | Position | State | Disease | Class | PMID |
---|---|---|---|---|---|
T | 183 | D | Alzheimer's disease | Phosphorylation | 23474850 |
T | 183 | D | Short-term oestrogen deprivation | Phosphorylation | 23474850 |
T | 183 | U | Alzheimer's disease | Phosphorylation | 23474850 |
T | 183 | U | Short-term oestrogen deprivation | Phosphorylation | 23474850 |
State Note: Based on the distinct PTM states in diseases, PTMD classified all disease-associated PTMs into six classes, including whether the up-regulation (U) or down-regulation (D) of PTM levels, the absence (A) or presence (P) of PTMs, and the creation (C) or disruption (N) of PTM sites are associated with diseases.
PTM-Drug Perturbation Response:
source: DecryptMNo data.
Function score:
source: funscoRNo data.